A detailed history of Baird Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 464,260 shares of DXCM stock, worth $36.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
464,260
Previous 914,553 49.24%
Holding current value
$36.9 Million
Previous $104 Million 69.99%
% of portfolio
0.06%
Previous 0.22%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $28.8 Million - $52.3 Million
-450,293 Reduced 49.24%
464,260 $31.1 Million
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $6.86 Million - $8.74 Million
-62,208 Reduced 6.37%
914,553 $104 Million
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $1.53 Million - $1.87 Million
-13,372 Reduced 1.35%
976,761 $135 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $5.91 Million - $9.71 Million
78,239 Added 8.58%
990,133 $123 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $9.41 Million - $15.1 Million
109,397 Added 13.63%
911,894 $85.1 Million
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $15 Million - $17.5 Million
133,299 Added 19.92%
802,497 $103 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $450,320 - $532,243
4,330 Added 0.65%
669,198 $77.7 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $2.98 Million - $3.68 Million
39,027 Added 6.07%
681,840 $54.9 Million
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $32.9 Million - $64.4 Million
484,394 Added 305.77%
642,813 $47.9 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $372,462 - $515,461
3,959 Added 2.56%
158,419 $81 Million
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $7.13 Million - $8.95 Million
-54,939 Reduced 26.24%
154,460 $82.9 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $255,570 - $342,916
-2,395 Reduced 1.13%
209,399 $115 Million
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $5.41 Million - $7.2 Million
66,738 Added 46.01%
211,794 $90.4 Million
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $800,926 - $989,374
-9,446 Reduced 6.11%
145,056 $52.1 Million
Q4 2020

Feb 11, 2021

SELL
$78.0 - $104.5 $535,626 - $717,601
-6,867 Reduced 4.26%
154,502 $57.1 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $504,197 - $596,263
-5,279 Reduced 3.17%
161,369 $66.5 Million
Q2 2020

Oct 22, 2020

SELL
$62.68 - $105.34 $3.07 Million - $5.16 Million
-48,937 Reduced 22.7%
166,648 $67.6 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $3.13 Million - $5.27 Million
-49,999 Reduced 18.83%
215,585 $47.2 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $2.34 Million - $3.7 Million
48,945 Added 22.59%
265,584 $71.5 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $7.93 Million - $12.4 Million
216,639 New
216,639 $47.4 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.